MLL-rearranged (MLL-r) leukemias can be clinically characterized as acute lymphocytic leukemia (ALL) or acute myeloid leukemia (AML) with a poor prognosis [1,2,3,4,5]. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.